Effect of antidepressants for cessation therapy in betel-quid use disorder: a randomised, double-blind, placebo-controlled trial

AIMS: More than one-half of betel-quid (BQ) chewers have betel-quid use disorder (BUD). However, no medication has been approved. We performed a randomised clinical trial to test the efficacy of taking escitalopram and moclobemide antidepressants on betel-quid chewing cessation (BQ-CC) treatment. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Chung-Chieh, Lee, Chien-Hung, Ko, Albert Min-Shan, Lane, Hsien-Yuan, Lee, Chi-Pin, Ko, Ying-Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216045/
https://www.ncbi.nlm.nih.gov/pubmed/32370818
http://dx.doi.org/10.1017/S2045796020000384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216045/
https://www.ncbi.nlm.nih.gov/pubmed/32370818
http://dx.doi.org/10.1017/S2045796020000384

Ejemplares similares